Sign inJoin waitlistJoin the waitlist

Kevin Ess

Division Chief · Vanderbilt University Medical Center

Credentials: · · · ·

History

Vanderbilt University Medical Center
Present
Section of Child Neurology · University of Colorado School of Medicine
Present
University of Colorado School of Medicine
Present

University of Colorado School of Medicine
2006–2007
University of Colorado School of Medicine
2002–2006
Pediatrics
Washington University/B-JH/SLCH Consortium
1999–2002
Washington University School of Medicine
1997–2002
University of Colorodo; Pediatric Internship
1998–1999
University of Cincinnati College of Medicine
1994–1998

Research

Interaction with WDR5 promotes target gene recognition and tumorigenesis by MYC
Molecular Cell · 2015 · 253 citations
Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND Checklist
Pediatric Neurology · 2015 · 230 citations
Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from…
MMWR Morbidity and Mortality Weekly Report · 2021 · 162 citations

Robert Carson
13 papers
Cary Fu
7 papers
Laura Armstrong
7 papers · 6 as a resident
MS
Mustafa Sahin
7 papers
Charles Hong
5 papers
Alfred George
4 papers
David Gutmann
4 papers
Kevin Kumar
4 papers
NK
Nathaniel Kelm
4 papers
Bret Mobley
3 papers
DW
David Witte
3 papers
John Snow
3 papers

Grants

Identifying mTOR Dependent Periods During Brain Development
National Institute of Neurological Disorders and Stroke · R01
PI · $2.1M · University of Colorado Denver
2020–2026
Drug Development for Tuberous Sclerosis Complex and Other Pediatric Epileptogenic Diseases Using Neurovascular and Cardiac Microphysiological Models
National Center for Advancing Translational Sciences · UH3
PI · $4.6M · Vanderbilt University
2017–2023
Drug Development for Tuberous Sclerosis Complex and Other Pediatric Epileptogenic Diseases Using Neurovascular and Cardiac Microphysiological Models
National Center for Advancing Translational Sciences · UG3
PI · $2.5M · Vanderbilt University
2017–2019
7th Symposium on ATP1A3 Function in Health and Disease
National Institute of Neurological Disorders and Stroke · R13
PI · $15K · Wake Forest University Health Sciences
2018–2019

Clinical trials

Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
Site PI · Recruiting · Phase 2
Darcy Krueger
2021–2027